Freedman Lori (CIK 0001410291)

Latest company ownership

ORGO - Organogenesis Holdings Inc.
Role: Chief Admin. and Legal Officer
Shares held
846,459
Last filed at
Jun 6, 2025
Confidence Score
51.9
2025Q4
Confidence Score History
2021Q2 2025Q4
EYPT - EyePoint Pharmaceuticals, Inc.
Role: VP Corp. Affairs, GC and Sec
Shares held
4,464
Last filed at
Jun 18, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 4, 2025 Jun 6, 2025 Organogenesis Holdings Inc. Chief Admin. and Legal Officer Buy 97.5 +252,264 42.45% ✗ $725.3K
Feb 15, 2025 Feb 19, 2025 Organogenesis Holdings Inc. Chief Admin. and Legal Officer Sell 22.5 -37,124 -7.91% ✗ $137.4K
Apr 1, 2024 Apr 3, 2024 Organogenesis Holdings Inc. Chief Admin. and Legal Officer Sell 45.0 -1,974 -0.42% ✗ $5.5K
Feb 15, 2024 Feb 20, 2024 Organogenesis Holdings Inc. Chief Admin. and Legal Officer Sell 22.5 -25,805 -7.50% ✗ $94.8K
Apr 1, 2023 Apr 4, 2023 Organogenesis Holdings Inc. Chief Admin. and Legal Officer Sell 37.5 -2,339 -0.68% ✗ $5K
Feb 15, 2023 Feb 17, 2023 Organogenesis Holdings Inc. VP and General Counsel Sell 26.3 -4,400 -6.12% ✗ $12.7K
Apr 1, 2022 Apr 5, 2022 Organogenesis Holdings Inc. VP and General Counsel Sell 26.3 -2,984 -3.99% ✗ $23.5K
Feb 15, 2022 Feb 17, 2022 Organogenesis Holdings Inc. VP and General Counsel Sell 90.0 +41,078 121.71% ✗ $6K
Apr 1, 2021 Apr 5, 2021 Organogenesis Holdings Inc. VP and General Counsel Sell 26.3 -1,975 -5.53% ✗ $39.2K
Jun 16, 2014 Jun 18, 2014 EyePoint Pharmaceuticals, Inc. VP Corp. Affairs, GC and Sec Sell 41.3 -7,900 -3.94% ✓ $31.6K
Jun 12, 2014 Jun 16, 2014 EyePoint Pharmaceuticals, Inc. VP Corp. Affairs, GC and Sec Sell 36.3 -11,700 -5.72% ✓ $47K
May 5, 2014 May 7, 2014 EyePoint Pharmaceuticals, Inc. VP Corp. Affairs, GC and Sec Sell 41.3 -3,500 -3.50% ✓ $14K